Position in ARGX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$80,983,187
+$11,424,684 QoQ
Shares Held
87,288
-8.4% QoQ
Ownership
0.140%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#47
of 505 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FEDERATED HERMES, INC. holds $2,455,215,104 across 149 Biotechnology names. ARGX ranks #7 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
719,905 | $216,713,000 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,785,716 | $198,268,046 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,884 | $160,177,448 | |
| 4 | MRNA |
Moderna, Inc.
|
1,794,778 | $125,688,301 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
749,398 | $85,933,468 | |
| 6 | EYPT |
EyePoint, Inc.
|
5,681,052 | $81,239,042 | |
| 7 | ARGX |
Argenx SE
This page
|
87,288 | $80,983,187 | |
| 8 | ZBIO |
Zenas BioPharma, Inc.
|
3,116,805 | $79,104,510 |
All Filings in ARGX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $80,983,187 | 87,288 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $69,558,503 | 95,253 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $89,788,231 | 106,770 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $91,622,652 | 124,224 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $68,163,313 | 123,659 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $64,480,731 | 108,945 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $104,701,905 | 170,247 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $114,456,939 | 211,144 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $109,397,874 | 254,390 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $105,687,834 | 268,434 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $135,625,957 | 356,507 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $163,265,897 | 332,091 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $130,256,729 | 334,223 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $128,992,411 | 346,214 | Shares | Defined | 2023-05-08 | |
| 2022-12-31 | $143,580,736 | 379,011 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $156,626,042 | 443,637 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $168,010,925 | 443,441 | Shares | Defined | 2022-09-16 | |
| 2022-03-31 | $144,608,102 | 458,622 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $174,872,978 | 499,366 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $131,029,948 | 433,874 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $130,980,201 | 435,049 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $128,143,097 | 465,315 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $138,345,229 | 470,418 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $123,735,125 | 471,336 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $104,737,580 | 465,025 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $48,030,206 | 364,611 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||